EFTA01592242Set 10
2007-07-0252p16,750w
Financial Trust Co. CREDIT-SUISSE FIRST
BOSTON (52,869) BOND
10000606 AMGN 0 3/32 AMGEN 0%
3/32 -2000 -15846U0 -1584660 9/27/2005
12663375 BUY 9/27/2005 ... HBFT Highbridge - Financial Trust
Co. CREDIT-SUISSE FIRST BOSTON 2 STOCK
100186 AMGN.O Amgen 545 44061.41 44061.41
9/27/2005 12663372 SHT 9/27/2005 1 2,391
2,391 - 2,391 12967168 1/12/2006 ... HBFT
Highbridge - Financial Trust Co. CREDIT-SUISSE FIRST BOSTON
739 STOCK
100186 AMGN.O Amgen 655 52954.54 52954.54
9/27/2005 12663372 SHT 9/27/2005 1 3,141
3,141 - 3,141 12988927 1/20/2006
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01592242.pdf
EFTA01593122Set 10
2006-02-0132p3,505w
FINANCING RETURN
FROM 746FY0 TO 2F8EE0
S/D FINANCING
FROM 2F8EE0 TO 746FY0
-1,500 AMGEN
OFFSHORE ARRANGING FLIP
TO 736FY0 FROM 746FY0
4,000 AMGEN
EFTA01593136
OFFSHORE ARRANGING FLIP ... 736FY0 FROM 746FY0
1,500 AMGEN
-4,000 AMGEN
76.56110
DONE AT EDGETRADE.COM INC.
79.19890
DONE AT EDGETRADE.COM ... MANA
-940 VALASSIS COMMUNICATIONS INC
OFFSHORE ARRANGING FLIP
TO 736FY0 FROM 746FY0
-1,950 AMGEN
OFFSHORE ARRANGING FLIP
TO 736FY0 FROM 746FY0
-7,400 SUPERVALU INC
OFFSHORE ARRANGING FLIP
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01593122.pdf
EFTA01088033Set 9
2016-04-1921p9,988w
correlated—see Chart 6. Today, US Biotech/Health Care is only
AMGN Amgen Inc. 118,509 1.64 34.6%
CELG Celgene Corporation 84,174 1.57 35.8%
one-third active, two-thirds passive ... overall value.
6 Biotechnology 19 April 2016 Bankof Amenca 40"
Merrill Lynch
EFTA01088038
Amgen (AMGN) I Neutral I C-2-7 I $181
AMGN has one of the larger product ... orphan products, (3) failure to advance key pipeline products, including Soliris in
new indications.
Amgen Inc. (AMGN)
Our price objective of 5181 is based on a 17x multiple
https://www.justice.gov/epstein/files/DataSet%209/EFTA01088033.pdf
EFTA00598607Set 9
2014-07-2313p8,093w
public offering (or 144A offering) of securities of Akebia TherapeuticsInc.
AMAG Pharmaceuticals, Inc., Amgen Inc., Celgene Corp. Chimerix Inc, Cubist Pharmaceuticals Inc., Gilead Sciences Inc., GW Pharmaceuticals
PLC. Ironwood Pharmaceuticals ... received compensation for investment banking services from Akebia Therapeutics Inc, AMAG
Pharmaceuticals. Inc.. Amgen Inc.. Biogen Mac Inc.. Celgene Corp, Chimerix Inc Cubist Pharmaceuticals Inc.. Gilead ... investment banking services from Akebia
Therapeutics Inc. Alexion -Pharmaceuticals. Alnylam.Pharmaceuticals, AMAG Pharmaceuticals, Inc.. Amgen Inc., Auxilium Pharmaceuticals.
Slogan idec Inc.. Colgan. Corp. Chimerix Inc. Cubist Pharmaceuticals
https://www.justice.gov/epstein/files/DataSet%209/EFTA00598607.pdf
EFTA01199408Set 9
2014-07-2313p8,089w
public offering (or 144A offering) of securities of Akebia TherapeuticsInc.
AMAG Pharmaceuticals, Inc., Amgen Inc., Celgene Corp. Chimerix Inc, Cubist Pharmaceuticals Inc., Gilead Sciences Inc., GW Pharmaceuticals
PLC. Ironwood Pharmaceuticals ... received compensation for investment banking services from Akebia Therapeutics Inc, AMAG
Pharmaceuticals. Inc.. Amgen Inc.. Biogen Mac Inc.. Celgene Corp, Chimerix Inc Cubist Pharmaceuticals Inc.. Gilead ... investment banking services from Akebia
Therapeutics Inc. Alexion -Pharmaceuticals. Alnylam.Pharmaceuticals, AMAG Pharmaceuticals, Inc.. Amgen Inc., Auxilium Pharmaceuticals.
Slogan idec Inc.. Colgan. Corp. Chimerix Inc. Cubist Pharmaceuticals
https://www.justice.gov/epstein/files/DataSet%209/EFTA01199408.pdf
EFTA00598622Set 9
14p8,563w
public offering (or 144A offering) of securities of Akebia Therapeutics Inc.
AMAG Pharmaceuticals, Inc., Amgen Inc., Celgene Corp. Chimenx Inc. Cubist Pharmaceuticals Inc., Gilead Sciences Inc.. GW Pharmaceuticals ... received compensation for investment banking services from Akebia Therapeutics Inc, AMAG
Pharmaceuticals. Inc.. Amgen Inc.. Biogen Idec Inc., Celgene Corp. Chimerix Inc, Cubist Pharmaceuticals Inc., Gilead Sciences ... Stanley has received compensation for products and services other than investment banking services from
Amgen Inc.. Auxilium Pharmaceuticals. Biogen Mee Inc., Celgene Corp. Cubist Pharmaceuticals Inc., Vertex Pharmaceuticals.
Within
https://www.justice.gov/epstein/files/DataSet%209/EFTA00598622.pdf
EFTA01592907Set 10
2005-10-0137p4,144w
FINANCING RETURN
FROM 746FY0 TO 2F8EE0
S/D FINANCING
FROM 2F8EE0 TO 746FY0
-1,670 AMGEN
OFFSHORE ARRANGING FLIP
TO 736FY0 FROM 746FY0
EFTA01592930
-1,400 DUKE ENERGY CORP
OFFSHORE ARRANGING ... 736FY0 FROM 746FY0
1,400 DUKE ENERGY CORP
600 CSX CORPORATION
1,670 AMGEN
DONE AT EDGETRADE.COM INC.
S/D FINANCING RETURN
FROM 746FY0 TO 2F8EE0
S/D FINANCING
FROM 2F8EE0 ... QUANTITY DESCRIPTION
S/D FINANCING
FROM 2F8EE0 TO 746FY0
FUNDS RECEIVED BY WIRE
-2,000 AMGEN
OFFSHORE ARRANGING FLIP
TO 736FY0 FROM 746FY0
-16,100 INTERNATIONAL GAME TECHNOLOGIES
TO 736FY0 FROM
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01592907.pdf
EFTA01199422Set 9
14p8,572w
received compensation for investment banking services from Akebia Therapeutics Inc, AMAG
Pharmaceuticals. Inc.. Amgen Inc.. Biogen Idec Inc., Celgene Corp. Chimerix Inc, Cubist Pharmaceuticals Inc., Gilead Sciences ... Stanley has received compensation for products and services other than investment banking services from
Amgen Inc., Auxilium Pharmaceuticals. Biogen Mee Inc., Celgene Corp. Cubist Pharmaceuticals Inc., Vertex Pharmaceuticals.
Within ... with, the following company: Akebia Therapeutics Inc, Alexion Pharmaceuticals. Alnylam Pharmaceuticals. AMAG Pharmaceuticals.
Inc., Amgen Inc., Auxilium Pharmaceuticals, Biogen Idec Inc., Celgene Corp, Chimerix Inc. Cubist Pharmaceuticals Inc.. Gilead
https://www.justice.gov/epstein/files/DataSet%209/EFTA01199422.pdf
EFTA01593617Set 10
2005-10-0151p5,116w
MARK TO MARKET
MARK TO MARKET
MARK TO MARKET
MARK TO MARKET
1,670 AMGEN
OFFSHORE ARRANGING FLIP
TO 736FY0 FROM 746FY0
1,400 DUKE ENERGY CORP
OFFSHORE ARRANGING FLIP ... 736FY0
746FY0 TO 736FY0 USD/EUR
MARK TO MARKET
MARK TO MARKET
2,000 AMGEN
OFFSHORE ARRANGING FLIP
TO 736FY0 FROM 746FY0
16,100 INTERNATIONAL GAME TECHNOLOGIES
TO 736FY0 FROM 746FY0 ... 10/27 MRKD/MARKET
01 10/28 JOURNAL
01 10/28 MRKD/MARKET
QUANTITY DESCRIPTION
MARK TO MARKET
790 AMGEN
OFFSHORE ARRANGING FLIP
TO 736FY0 FROM 746FY0
-790 AMGEN
OFFSHORE ARRANGING FLIP
TO 736FY0 FROM
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01593617.pdf
EFTA01582479Set 10
2006-02-011p212w
CREDIT
03 02/23 MRKD/MARKET MARK TO MARKET 185,761.01
03 02/23 JOURNAL -1,000 AMGEN 74,022.97
OFF A 4
TO
03 02/23 JOURNAL ... 02/24 MRKD/MARKET MARK TO MARKET 3,966.99
03 02/24 JOURNAL -1,700 AMGEN 128,388.98
OFF
TO
03 02/24 JOURNAL -800 VORNADO REALTY TR 70,620.47
OFFc ... USD/EUR
01 02/27 MRKD/MARKET MARK TO MARKET 475,597.29
01 02/27 JOURNAL 2,500 AMGEN
JNL SHORT A/C TO MARGIN A/C
01 02/27 JOURNAL -940 VALASSIS COMMUNICATIONS INC
CLOSE SHORT
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01582479.pdf
EFTA01592748Set 10
2005-09-0129p3,227w
2F8EE0
S/D FINANCING
FROM 2F8EE0 TO 746FY0
FUNDS RECEIVED BY WIRE
-2,000,000 AMGEN INC NT ZER CV 32
03/01/2032
OFFSHORE ARRANGING FLIP
TO 736FY0 FROM 746FY0 ... AMGEN
OFFSHORE ARRANGING FLIP
TO 736FY0 FROM 746FY0
2,000,000 AMGEN INC NT ZER CV 32
03/01/2032
DONE AT MORGAN, STANLEY AND
COMPANY, INCORPORATED
-9,740 AMGEN
DONE
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01592748.pdf
EFTA01168775Set 9
2015-09-2838p11,652w
Obama Scholar- 2012 to Present
•Regent High Honors Scholar-2012 to Present
•Harvard-Amgen Scholarship- 2015
o 1 of 20 students selected for this highly competitive program to conduct research ... selected to conduct research in the No.1 cancer
hospital
oTurned down offer for Harvard-Amgen Scholarship
•American Association for the Advancement of Science Travel Grant- 2014
o Awarded ... Choueiri, Susan Su, Michael E. Greenberg. Neuronal BRD4 regulates
activity-dependent gene expression. Harvard- Amgen Scholars Oral Presentations at Harvard
University, 2015. Presentation
Alexi Choueiri, Susan Su, Michael E. Greenberg
https://www.justice.gov/epstein/files/DataSet%209/EFTA01168775.pdf
EFTA01593382Set 10
2006-03-0126p2,914w
FROM 2F8EE0 TO 746FY0
FUNDS RECEIVED BY WIRE
746FY0 HIGHBRIDGE CAPITAL MANA
-2,000 AMGEN
EFTA01593396
OFFSHORE ARRANGING FLIP
TO 736FY0 FROM 746FY0
-1,500 VALASSIS COMMUNICATIONS INC
OFFSHORE ARRANGING ... JOURNAL
01 03/16 BOUGHT
03 03/16 BOUGHT
01 03/17 JOURNAL
QUANTITY DESCRIPTION
2,000 AMGEN
DONE AT EDGETRADE.COM INC.
1,500 VALASSIS COMMUNICATIONS INC
DONE AT EDGETRADE.COM INC.
S/D FINANCING ... SOLD
01 03/21 JOURNAL
QUANTITY DESCRIPTION
S/D FINANCING
FROM 2F8EE0 TO 746FY0
1,000 AMGEN
OFFSHORE ARRANGING FLIP
TO 736FY0 FROM 746FY0
1,500 VORNADO REALTY TR
OFFSHORE ARRANGING FLIP
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01593382.pdf
EFTA01593346Set 10
2006-04-0136p3,620w
FINANCING RETURN
FROM 746FY0 TO 2F8EE0
S/D FINANCING
FROM 2F8EE0 TO 746FY0
-2,000 AMGEN
OFFSHORE ARRANGING FLIP
TO 736FY0 FROM 746FY0
-3,540 SUPERVALU INC
OFFSHORE ARRANGING FLIP ... CORP
DONE AT EDGETRADE.COM INC.
3,540 SUPERVALU INC
2,000 AMGEN
EFTA01593370
29.41860
DONE AT EDGETRADE.COM INC.
70.17210
DONE AT EDGETRADE.COM ... 746FY0
736FY0 TO 746FY0 USD/VAR
S/D FINANCING RETURN
FROM 746FY0 TO 2F8EE0
-600 AMGEN
OFFSHORE ARRANGING FLIP
TO 736FY0 FROM 746FY0
600 AMGEN
DONE AT EDGETRADE.COM INC.
S/D FINANCING RETURN
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01593346.pdf
EFTA01593563Set 10
2005-11-0154p5,367w
11/15 MRKD/MARKET
03 11/15 MRKD/MARKET
03 11/15 JOURNAL
QUANTITY DESCRIPTION
MARK TO MARKET
-685 AMGEN
OFFSHORE ARRANGING FLIP
TO 736FY0 FROM 746FY0
MARK TO MARKET
FUNDS PAID BY WIRE
WIRE ... MARKET
FUNDS PAID BY WIRE
WIRE TO CITIBANK
MARK TO MARKET
-3,200 AMGEN
OFFSHORE ARRANGING FLIP
TO 736FY0 FROM 746FY0
MARK TO MARKET
FUNDS PAID BY WIRE
WIRE ... Poor's
17,250 (S) AMERICAN FINL GROUP INC
*CSFB RATING
9,955 (S) AMGEN
*CSFB RATING
:NEUTRAL
INDEPENDENT RATING:5 STAR - Buy
PROVIDER:Standard & Poor's
37.15000
:OUTPERFORM
INDEPENDENT
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01593563.pdf
EFTA01581897Set 10
2005-09-011p217w
09/30 WIRED FUNDS RECEIVED BY WIRE 16,029.00
01 09/30 JOURNAL -2,000, 000 AMGEN INC NT ZER CV 32 1,584,660.00
03/01/2032
OFFSHORE ARRANGING FLIP
TO FROM ... 09/30 JOURNAL 9, 740 AMGEN 7 87, 44 6.0 8
OFFSHORE ARRANGING FLI P
TO FROM
01 09/30 BOUGHT 2,000, 000 AMGEN ... 03/01/2032
DONE AT MORGAN, STANLEY AND
COMPANY, INCORPORATED
03 09/30 SOLD -9, 74 0 AMGEN 80 .8 500 0 787 , 9 46.08
DONE AT MORGAN, STANLEY AND
COMPANY, INCORPORATED
CREDIT
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01581897.pdf
EFTA01582101Set 10
2006-09-011p153w
TYPE DATE TRANSACTION QUANTITY DESCRIPTION PRICE DEBIT CREDIT
01 09/22 JOURNAL 2,000,000 AMGEN INC NT ZER CV 32 1,488,750.00
03/01/2032
OFFSHORE ARRANGING FLIP
TO FROM ... 09/22 JOURNAL -1,060 AMGEN 74,024.08
OFFSHORE ARRANGING FLIP
TO rip FROM
03 09/22 JOURNAL -1,245 MAS P 34,051.88
03 09/22 BOUGHT 1,245
rig
OFFSHORE ARRANGING ... FROM
27.34550 34,051.88
DONE AT EDGETRADE.COM INC.
01 09/22 SOLD -2,000,000 AMGEN INC NT ZER CV 32 74.43750 1,488,750.00
03/01/2032
DONE AT MERRILL LYNCH, PIERCE
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01582101.pdf